Germany: Gilde Healthcare sells RAD-x to Swiss Life and Vesper AM
Swiss Life Asset Managers and Vesper Next Generation Infrastructure Fund I have agreed to acquire RAD-x from specialized healthcare investor Gilde Healthcare’s Private Equity...
Germany: Ottobock returns to Näder family following buy back of EQT stake
After more than six years of partnership with EQT, Ottobock, a healthtech company specialising in prosthetics, will return to the Näder family.
Näder Holding, the management...
France: AstraZeneca to acquire Amolyt Pharma for US$1.05bn
Amolyt Pharma, a France-headquartered global, clinical-stage biopharmaceutical company specializing in developing therapeutic peptides for rare endocrine and related diseases, has entered into a definitive...
Switzerland: Galderma announces price range for upcoming IPO
Galderma Group, a pure-play dermatology firm, has announced the price range, published its prospectus and started the book-building process, as part of its intention...
UK: Ampersand acquires UK-based manufacturer of spectroscopy accessories
Ampersand Capital Partners, a mid-market private equity firm specializing in growth equity investments in the life sciences and healthcare sectors, has acquired UK-based Specac,...
UK: PLG strengthens digital capabilities with Integrity
France based ProductLife Group (PLG), a provider of healthcare consulting and outsourcing services, is strengthening its capability to provide global digital consulting services with...
UK: Inflexion announces final close of Partnership Capital Fund III at £1.75bn
Inflexion, a European mid-market private equity firm, has announced the final close of Inflexion Partnership Capital Fund III at its hard cap of £1.75bn...
UK: Aspire Pharma strengthens specialty pharma offering with acquisition of Cenoté Pharma
Aspire Pharma, a specialty generics business, has supplemented its organic growth with the acquisition of Cenoté Pharma, a category specialist in carnitine deficiencies.
Financial terms...
Sweden: Vimian announces plans rights issue to finance M&A
Vimian, a global animal health company covering four areas: Specialty Pharma, MedTech, Diagnostics, and Veterinary Services, has announced its intention to raise up to...
Sweden: Flerie Invest triggers mandatory bid offer for Lipum
Life science investor, Flerie Invest, has passed the threshold for a mandatory bid for Lipum, a clinical stage biopharmaceutical company specialized in discovery and...
Advertisement
